$CLDX Recent Headlines Stock leaders flex muscles 1:58

New Post Public Reply Private Reply Replies (0) Message Board

Mar 3, 2014 at 11:49 AM

$CLDX Recent Headlines

Stock leaders flex muscles 1:58 p.m. Feb. 27, 2014 - The Trading Deck
S&P 500 rattles the cage on latest all-time high 11:28 a.m. Feb. 24, 2014 - Michael Ashbaugh
This tiny mutual fund is no. 1 for 2013 7:33 a.m. Jan. 7, 2014 - Suzanne McGee
Reading Wall Street’s tea leaves 2:44 p.m. Dec. 6, 2013 - The Trading Deck
Monthly jobs report triggers technical whipsaw 11:23 a.m. Sept. 6, 2013 - Michael Ashbaugh
Charting a market divergence 10:21 a.m. Aug. 22, 2013 - Michael Ashbaugh
Six stocks on the move 1:42 p.m. Aug. 21, 2013 - The Trading Deck
Charting a slow-motion test of major resistance 10:10 a.m. July 3, 2013 - Michael Ashbaugh
S&P 500 hesitates at the breakdown point 10:14 a.m. June 26, 2013 - Michael Ashbaugh
3 longs and 3 shorts to watch 2:22 p.m. June 12, 2013 - The Trading Deck
3 longs and 3 shorts to watch 1:33 p.m. April 17, 2013 - The Trading Deck
Hedge Funds have bought these stocks recently 2:04 p.m. April 12, 2013 - Insider Monkey
Hedge funds are bullish on these 5 stocks 7:38 a.m. Jan. 3, 2013 - Insider Monkey
Thursday’s top gaining and declining stocks 2:24 p.m. May 24, 2012 - MarketWatch
Friday’s biggest gaining and declining stocks 4:40 p.m. Feb. 24, 2012 - Kate Gibson
Celldex prices shares at 12% discount 11:26 a.m. Feb. 24, 2012 - MarketWatch.com
Rindopepimut ups brain cancer survival: Celdex 2:29 p.m. Nov. 21, 2011 - MarketWatch.com
Wednesday’s biggest gaining and declining stocks 2:33 p.m. May 18, 2011 - Kate Gibson
Celldex, Shire in drug-sector spotlight 12:35 p.m. May 18, 2011 - Val Brickates Kennedy
Celldex Therapeutics offer prices at 19% discount 8:48 a.m. May 18, 2011 - MarketWatch.com

10-K: CELLDEX THERAPEUTICS, INC. 10 min ago - Edgar Online - (EDG = 10Q, 10K)
Northwest Bio: Interim Analysis of Brain Cancer Vaccine Study Past Due 10:32 a.m. Today - TheStreet.com
Celldex Therapeutics, Inc Discusses Q1 2014 Results (Webcast) 8:25 a.m. Today - Seeking Alpha
Eotaxin-1 Inhibition - The Next PD(L)-1 In Inflammatory Disease? 10:23 a.m. Feb. 21, 2014 - Seeking Alpha
Catalysts Drive These Stocks: Mara Goldstein 9:20 a.m. Feb. 21, 2014 - Seeking Alpha
Agenus: Acquisition Of 4-Antibody Is A Transformational Move 1:28 p.m. Feb. 20, 2014 - Seeking Alpha
Celldex Therapeutics Inc. (CLDX): Today's Featured Health Care Laggard 5:01 p.m. Feb. 13, 2014 - TheStreet.com
Use Options For A Chance To Buy CLDX At A 62% Discount 11:42 a.m. Feb. 13, 2014 - TheStreet.com
Do Away With The Pill-A-Day Biotech Model: Steve Brozak 2:05 p.m. Feb. 7, 2014 - Seeking Alpha
Combination Therapies: Where Immuno-Oncology Is Headed And How To Invest 8:55 a.m. Feb. 6, 2014 - Seeking Alpha
Seattle Genetics Will Exceed And Immunogen Will Meet Market Expectations 11:09 a.m. Jan. 25, 2014 - Seeking Alpha
First Week Of March 22nd Options Trading For Celldex Therapeutics (CLDX) 1:20 p.m. Jan. 22, 2014 - TheStreet.com
Cramer's Mad Money - 10 Trends Moving Stocks (1/21/14) 6:17 a.m. Jan. 22, 2014 - Seeking Alpha
Sell Watch: Zeltiq Has Become Over-Speculated 9:20 a.m. Jan. 21, 2014 - Seeking Alpha
Use Options For A Chance To Buy CLDX At A 58% Discount 11:43 a.m. Jan. 15, 2014 - TheStreet.com
Cantor Fitzgerald Shows Best Global Equity Research Ideas for 2014 8:00 a.m. Jan. 15, 2014 - 247WallSt.com
5 Biotech Stocks With Big Catalysts on the Horizon 3:26 a.m. Jan. 15, 2014 - InvestorPlace.com
Best Biotech Ideas for 2014 1:35 p.m. Jan. 11, 2014 - Barrons.com
Celldex Therapeutics: Can an Orphan Program Create Larger Gains? 11:17 a.m. Jan. 8, 2014 - Wall St. Cheat Sheet
Oppenheimer Sees Five Biotech Stocks to Buy With Potential 50% Upside, or More 7:46 a.m. Jan. 7, 2014 - 247WallSt.com

Celldex Reports Fiscal 2013 Business/Financial Results and Outlines 2014 Strategy 8:03 a.m. Today - GlobeNewswire
Celldex to Report Fourth Quarter and Fiscal 2013 Business/Financial Results and Host 2014 Strategy Conference Call 1:30 p.m. Feb. 25, 2014 - GlobeNewswire
Critical Alerts For AT&T, Mastercard, Disney, Du Pont, and Celldex Therapeutics Released By InvestorsObserver 9:31 a.m. Feb. 12, 2014 - PR Newswire - PRF
Celldex Announces Upcoming Presentation at the 2014 Leerink Global Healthcare Conference 11:00 a.m. Feb. 6, 2014 - GlobeNewswire
Mentor Capital Cancer Immunotherapy Index Up 97% in 2013 11:02 a.m. Jan. 21, 2014 - BusinessWire - BZX
Critical Alerts For Facebook, DirecTV, Du Pont, BIDU, and Celldex Released By InvestorsObserver 9:31 a.m. Jan. 9, 2014 - PR Newswire
Retirement Announcements, Stock Price Movements, and Scheduled Conferences Presentations - Research Report on Gilead, Aegerion, Celldex, Alnylam, and Ironwood 8:00 a.m. Jan. 9, 2014 - PR Newswire
Clinical Study Updates, Collaborations, and Stock Price Updates - Research Report on Medtronic, Regeneron, Celldex, Cubist, and MannKind 8:00 a.m. Dec. 31, 2013 - PR Newswire
Health Care Sector Technical Data: XOMA, Celldex Therapeutics, Illumina, and Immunomedics 8:12 a.m. Dec. 19, 2013 - PR Newswire
Share Price Movements and Clinical Studies - Research Report on Celldex Therapeutics, Envision, MannKind, Covance, and Auxilium 8:00 a.m. Dec. 19, 2013 - PR Newswire
Clinical Trial Results, Partnerships, and Reimbursement Rates - Research Report on Celldex, Centene, Enanta, Novartis, and BG Medicine 8:00 a.m. Dec. 13, 2013 - PR Newswire
New Clinical Trials, Pricing of Common Stock and Adjusted Conversion of Convertible Senior Notes - Research Report on Regeneron, Celldex, PDL BioPharma, Amedisys, and Exelixis 8:00 a.m. Dec. 11, 2013 - PR Newswire
Celldex's CDX-301 in Combination with Mozobil(R) Increases Hematopoietic Stem Cell Mobilization and Results in Improved Transplantation of Mobilized Cells in Preclinical Studies; Results Presented at ASH 2013 8:30 a.m. Dec. 10, 2013 - GlobeNewswire
Celldex Announces Exercise of Underwriters' Option to Purchase Additional Shares 5:03 p.m. Dec. 9, 2013 - GlobeNewswire
Stock Price Movements, Campaigns, New Clinical Studies, and Approvals- Research Report on Actavis, Ariad Pharmaceuticals, DaVita, Celldex, and WellCare 8:00 a.m. Dec. 5, 2013 - PR Newswire
Celldex Therapeutics Prices Public Offering of Common Stock 7:52 p.m. Dec. 4, 2013 - GlobeNewswire
Celldex Therapeutics Announces Proposed Public Offering of Common Stock 4:05 p.m. Dec. 3, 2013 - GlobeNewswire
Celldex Therapeutics Initiates METRIC, an Accelerated Approval Study of Glembatumumab Vedotin in Patients with Triple Negative Breast Cancer 7:00 a.m. Dec. 2, 2013 - GlobeNewswire
Celldex Announces Upcoming Presentation at the Deutsche Bank 2013 BioFEST 8:03 a.m. Nov. 27, 2013 - GlobeNewswire
Critical Alerts For Google, Philip Morris, Lockheed Martin, Celldex Therapeutics, and Anglogold Ashanti Released By InvestorsObserver 9:31 a.m. Nov. 26, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PlugClaw: TrustKernel's AI Gadget Tackles Privacy Hurdles

A Handy Revolution in AI Computing You know, every now and then, a gadget shows up that flips the scene on its head. Enter TrustKernel's PlugClaw. It's not every day you see a whole computer in something barely the size of your thumb, yet this one does exactly that. Weighing in at a measly 15 grams and armed with a MediaTek Helio G80, we're looking at a USB-C stick that's...

Cheetah Mobile Q2 2026 Results: What's on the Horizon?

Anticipation Builds for Cheetah Mobile's Q2 Results Nine rounds into the slugfest that is the 2026 market, we've got another round approaching—Cheetah Mobile is set to unveil its second quarter numbers on September 11th. This isn't some sleepy, run-of-the-mill report either; NYSE:CMCM is a player with skin in the IT game, and commentators are eyeing the clock with...

Chris Auffenberg Buick: 1.9% APR Drives New Deals

New Financing Options in Carbondale In a world where financing a car sometimes feels like predicting the weather—unreliable and erratic—Chris Auffenberg Buick is turning the tables down in Carbondale with a refreshing approach. They're trotting out a 1.9% APR financing option for those Buick lovers who qualify, all through GM Financial. It's the kind of deal that...

Fujifilm's New 400mm Lens: A Game Changer?

Big Moves from Fujifilm's Camp Now we're talking, Fujifilm! Just when you think they might ease off the throttle, they crank up the heat with the XF 400mm f/4.5 R LM OIS WR lens. This isn’t just your run-of-the-mill update. It's a significant addition to their already beefed-up lineup for sports and wildlife. You know what that means: more reach, less baggage. Compact...

Clinical Trials Services Market Set for Big Growth

Eyeing a Market Surge in Clinical Trials Numbers don't lie, and they're painting a promising picture for the clinical trials services market with a solid 8% growth forecasted annually till 2031. From a modest $66.20 billion in 2026, we're looking at ballooning to a hefty $97.41 billion by 2031. What’s cooking? Let me dish it out for you. Key Drivers and Dynamics North...

Acepodia's ACE723 Clears FDA Hurdle for Hepatocellular Push

Unexpected Developments from Acepodia Folks keeping a keen eye on the biotech scene might just raise an eyebrow at Acepodia's latest move. The FDA has given their nod to ACE723, an ambitious dual-payload antibody-drug conjugate (ADC) designed to wrangle with those stubborn cases of unresectable or metastatic hepatocellular carcinoma (HCC). This isn't just another day in...

NOVOSENSE's Bold Performance Amid Rapid IC Demand

Surge in Revenue Growth Marks a Milestone for NOVOSENSE Give a pat on the back to NOVOSENSE (HKEX: 02676), because reporting a robust 66.73% bump in first-half revenue isn't small potatoes in today's tech landscape. This translates to around $374.54 million rolling into their coffers, which is quite a spectacle if you're watching the trend of sequential revenue growth...

Graywind Redefines Flexibility with New Blinds 2.0

Sliding blinds—who knew they'd stir up such a fuss? But here comes Graywind, rolling out their Manual Sliding Track Blinds 2.0, and it's clear they're turning heads in Santa Clara and beyond. This ain't your grandma's drapery setup. We're talking about a sleek, mid-to-premium panel-track system designed to cater to modern living spaces and architectural whimsy. It's...

Dynamic Automotive’s Car Show: Connecting Cars & Community

Cars, Community, and Cause Today’s dialogue isn’t about upcoming IPOs or blue-chip stocks, it's about classic cars rolling into the spotlight for something bigger than horsepower or polish. On Sunday, September 27, from noon till three, Dynamic Automotive will host its 18th Annual Car Show in Urbana, Maryland. They’re not just showing off vintage steel; they’re...

Curaleaf Expands in Florida Amid Rising Cannabis Demand

Curaleaf's Bold Moves in Florida's Ganja Gold Rush Fresh out of the gate, Curaleaf is saddling up for a wild ride into Florida's cannabis frontier. They've just thrown open the doors of their latest dispensary in Riverview, cranking their statewide count up to 77. Now, isn’t that something? If you're tracking these folks, you know that bringing their nationwide total to...